Notice Pursuant to the National Cooperative Research and Production Act of 1993-Global Human Body Models Consortium, 7578 [06-1291]

Download as PDF 7578 Federal Register / Vol. 71, No. 29 / Monday, February 13, 2006 / Notices SUMMARY: The Committee on Rules of Practice and Procedure will hold a twoday meeting. The meeting will be open to public observation but not participation. DATES: June 22–23, 2006. TIME: 8:30 a.m. to 5 p.m. ADDRESSES: Thurgood Marshall Federal Judiciary Building, Judicial Conference Center, One Columbus Circle, NE., Washington, DC. FOR FURTHER INFORMATION CONTACT: John K. Rabieji, Chief, Rules Committee Support Office, Administrative Office of the United States Courts, Washington, DC 20544, telephone (202) 502–1820. Dated: February 6, 2006. John K. Rabiej, Chief, Rules Committee Support Office. [FR Doc. 06–1281 Filed 2–10–06; 8:45 am] Antitrust Division rwilkins on PROD1PC63 with NOTICES Notice Pursuant to the National Cooperative Research and Production Act of 1993—Global Human Body Models Consortium Notice is hereby given that, on January 19, 2006, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Global Human Body Models Consortium has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing (1) the identities of the parties to the venture and (2) the nature and objectives of the venture. The notifications were filed for the purpose of invoking the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Pursuant to Section 6(b) of the Act, the identities of the parties to the venture are: General Motors Corporation, Detroit, MI; DaimlerChrysler Corporation, Auburn Hills, MI; Honda R&D Co., Ltd., Tochigi, Japan; Hyundai Motor Company, Gyeonggi-do, Republic of Korea; Nissan Motor Co., Ltd., Kanagawa, Japan; TK Holdings, Auburn Hills, MI; Toyota Motor Corporation, Aichi, Japan; and TRW Vehicle Safety Systems, Inc., Washington, MI. The general area of Global Human Body Models Consortium’s planned activity is to conduct joint research and development necessary to create computer models of the human body (and/or portions thereof) and the body’s reaction to Jkt 208001 The last notification was filed with the Department on October 31, 2005. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on November 28, 2005 (70 FR 71333). Dorothy B. Fountain, Deputy Director of Operations, Antitrust Division. [FR Doc. 06–1289 Filed 2–10–06; 8:45 am] BILLING CODE 4410–11–M DEPARTMENT OF JUSTICE BILLING CODE 4410–11–M Drug Enforcement Administration DEPARTMENT OF JUSTICE Notice Pursuant to the National Cooperative Research and Production Act of 1993—Network Centric Operations Industry Consortium, Inc. DEPARTMENT OF JUSTICE 17:38 Feb 10, 2006 Dorothy B. Fountain, Deputy Director of Operations, Antitrust Division. [FR Doc. 06–1291 Filed 2–10–06; 8:45 am] Antitrust Division BILLING CODE 2210–55–M VerDate Aug<31>2005 external physical forces. The models would be used in vehicle and component testing. To accomplish this objective, the parties, working in conjunction as necessary with third parties such as government entities, universities and suppliers, will refine and improve current models and develop new ones. Notice is hereby given that, on January 23, 2006, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Network Centric Operations Industry Consortium, Inc. has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, International Data Links Society, San Diego, CA; Military Communication Institute, Zegrze, POLAND; and Maritime Technology Centre R&D Institute, Gdynia, POLAND have been added as parties to this venture. Also, SPARTA, Inc., Arlington, VA; AeroVironment, Inc., Simi Valley, CA; and Software Engineering Institute/ Carnegie Mellon University, Pittsburgh, PA have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and Network Centric Operations Industry Consortium, Inc. intends to file additional written notification disclosing all changes in membership. On November 19, 2004, Network Centric Operations Industry Consortium, Inc. filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on February 2, 2005 (70 FR 5486). PO 00000 Frm 00076 Fmt 4703 Sfmt 4703 Manufacturer of Controlled Substances; Notice of Registration; Correction By Notice dated July 19, 2005, and published in the Federal Register on July 27, 2005 (70 FR 43457), Siegfried (USA), Inc., was granted registration as a bulk manufacturer of the basic class of controlled substances listed in the notice. Oxycodone (9143) and Morphine (9300) were inadvertently omitted from the list of controlled substances for Siegfried (USA), Inc., Industrial Park Road, Pennsville, New Jersey 08070. The Notice of Registration published on July 27, 2005 (70 FR 43457), should be corrected to include Oxycodone (9143) and Morphine (9300). Dated: February 6, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6–1903 Filed 2–10–06; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF LABOR Office of the Secretary Submission for OMB Review: Comment Request February 7, 2006. The Department of Labor (DOL) has submitted the following public information collection request (ICR) to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995 (Pub. L. 104–13, 44 U.S.C. chapter 35). A copy of this ICR, with applicable supporting documentation, may be obtained by contacting the Department of Labor (DOL). To obtain documentation, contact Darrin King on 202–693–4129 (this is not a toll-free number) or e-mail: king.darrin@dol.gov. E:\FR\FM\13FEN1.SGM 13FEN1

Agencies

[Federal Register Volume 71, Number 29 (Monday, February 13, 2006)]
[Notices]
[Page 7578]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-1291]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Global Human Body Models Consortium

    Notice is hereby given that, on January 19, 2006, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Global Human Body Models 
Consortium has filed written notifications simultaneously with the 
Attorney General and the Federal Trade Commission disclosing (1) the 
identities of the parties to the venture and (2) the nature and 
objectives of the venture. The notifications were filed for the purpose 
of invoking the Act's provisions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances.
    Pursuant to Section 6(b) of the Act, the identities of the parties 
to the venture are: General Motors Corporation, Detroit, MI; 
DaimlerChrysler Corporation, Auburn Hills, MI; Honda R&D Co., Ltd., 
Tochigi, Japan; Hyundai Motor Company, Gyeonggi-do, Republic of Korea; 
Nissan Motor Co., Ltd., Kanagawa, Japan; TK Holdings, Auburn Hills, MI; 
Toyota Motor Corporation, Aichi, Japan; and TRW Vehicle Safety Systems, 
Inc., Washington, MI. The general area of Global Human Body Models 
Consortium's planned activity is to conduct joint research and 
development necessary to create computer models of the human body (and/
or portions thereof) and the body's reaction to external physical 
forces. The models would be used in vehicle and component testing. To 
accomplish this objective, the parties, working in conjunction as 
necessary with third parties such as government entities, universities 
and suppliers, will refine and improve current models and develop new 
ones.

Dorothy B. Fountain,
Deputy Director of Operations, Antitrust Division.
[FR Doc. 06-1291 Filed 2-10-06; 8:45 am]
BILLING CODE 4410-11-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.